FIGURE 1

![FIGURE 1: Study design flowchart for the randomized, assessor-blinded trial evaluating an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with androgenetic alopecia or telogen effluvium.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240182/bin/SRT-29-e13381-g003.jpg)

> Source: Massimo Milani et al. "Efficacy and tolerability of an oral supplement containing amino acids, iron, se." *Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)*, 2023. PMID: [37357646](https://pubmed.ncbi.nlm.nih.gov/37357646/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240182/bin/SRT-29-e13381-g003.jpg" alt="Study design flowchart for the randomized, assessor-blinded trial evaluating an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with androgenetic alopecia or telogen effluvium." />
  <figcaption>FIGURE 1. Study design flowchart for the randomized, assessor-blinded trial evaluating an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with androgenetic alopecia or telogen effluvium.<br>  Source: Massimo Milani et al. "Efficacy and tolerability of an oral supplement containing amino acids, iron, se." <em>Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37357646/">37357646</a></figcaption>
</figure>